成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 1219168-18-9 Chemical Structure| 1219168-18-9
Chemical Structure| 1219168-18-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 1219168-18-9

,{[proInfo.pro_purity]}

Dorsomorphin 2HCl is an AMPK inhibitor with an IC50 value of 109 nM for AMPK. Dorsomorphin 2HCl inhibits the BMP signaling pathway and can be used in research on stem cell differentiation and bone regeneration.

Synonyms: Compound C dihydrochloride; BML-275 dihydrochloride; CpdC

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Dorsomorphin 2HCl

CAS No. :1219168-18-9
Formula : C24H27Cl2N5O
M.W : 472.41
SMILES Code : [H]Cl.[H]Cl.C12=C(C3=CC=NC=C3)C=NN1C=C(C4=CC=C(OCCN5CCCCC5)C=C4)C=N2
Synonyms :
Compound C dihydrochloride; BML-275 dihydrochloride; CpdC
MDL No. :MFCD11112197
InChI Key :RJDVIJJQKMGPMV-UHFFFAOYSA-N
Pubchem ID :49761481

Safety of Dorsomorphin 2HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Dorsomorphin 2HCl

epigenetics
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
Human fetal lung fibroblasts (IMR-90 or MRC-5) 1 μM 4 days Promotes neuronal survival and maturation, synergizes with FSK to significantly enhance neuronal conversion efficiency PMC3843951
Clinical acute leukemia isolates 5 μM 24 h Enhanced cell death induced by navitoclax or S63845 PMC11043078
U937 cells 5 μM 24 h Inhibited AMPK activation and enhanced cell death induced by navitoclax or S63845 PMC11043078
Jurkat cells 5 μM 24 h Inhibited AMPK activation and enhanced cell death induced by navitoclax or S63845 PMC11043078
HepG2 cells 10 μM Dorsomorphin significantly reduced basal hepcidin expression in HepG2 cells and completely abolished BMP2-induced hepcidin expression. PMC2727650
Hep3B cells 10 μM 16 h Dorsomorphin abrogated BMP2- and HJV-induced hepcidin promoter activity. PMC2727650
C2C12 cells 4 μM 5 days Dorsomorphin almost completely abolished BMP4- and BMP6-induced alkaline phosphatase activity, indicating inhibition of BMP-induced osteogenic differentiation. PMC2727650
Mouse pulmonary artery smooth muscle cells (PASMCs) 0.47 μM 30 min Dorsomorphin inhibited BMP4-induced phosphorylation of SMAD1/5/8, but did not affect MAPK p38 activation. PMC2727650
Zebrafish embryos 0.312 μM or 0.625 μM 0.75 hpf to 24 hpf To investigate the effects of Dorsomorphin on early zebrafish embryogenesis, results showed that Dorsomorphin-treated embryos exhibited dorsalization phenotypes by 24 hpf. PMC6169527
Saos2 cells 5 μM Dorsomorphin inhibited the promoting effects of TMEM119 overexpression on Saos2 cell migration and invasion PMC5454443
FOP HDFs 1 μM 25 days Inhibits BMP-SMAD signaling, significantly reduces hiPSC generation from FOP HDFs PMC5135304
WT-hepatocytes 10 μM 9 h To investigate the reversal effect of Dorsomorphin on A23187-mediated glycogen deposition suppression, results showed that Dorsomorphin completely restored the A23187-mediated reduction in glycogen content. PMC11060962
WT-hepatocytes 1, 3, or 10 μM 9 h To investigate the reversal effect of Dorsomorphin on ethanol-mediated glycogen depletion, results showed that Dorsomorphin reversed the ethanol-mediated inhibition of glycogen levels in a dose-dependent manner. PMC11060962
3T3-L1 fibroblasts 1 μmol/mL 24 h To verify whether AMPK mediated the anti-fibrotic effect of ORM, results showed that dorsomorphin reversed the inhibitory effect of ORM on fibrotic markers. PMC8792011

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
BALB/c Nude mice Jurkat xenograft model Intraperitoneal injection 25 mg/kg Three times a week for two weeks Inhibited xenograft tumor growth without increasing toxicity in normal tissues PMC11043078
Zebrafish Zebrafish embryos Added to culture medium 10 μM Starting 4 h post fertilization (h.p.f.) and assessed visually at 24 and 48 h.p.f. Dorsomorphin treatment caused dorsalization of zebrafish embryos, manifested as expansion of dorsal structures and loss of ventral structures. PMC2727650
Rats Streptozotocin-induced diabetic peripheral neuropathy model Intraperitoneal injection 0.2 mg/kg Once daily for 15 days Dorsomorphin, as an AMPK inhibitor, was used to investigate the mechanism of Empagliflozin in diabetic peripheral neuropathy. The results showed that dorsomorphin almost completely abolished the beneficial effects of Empagliflozin. PMC9325846

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.12mL

0.42mL

0.21mL

10.58mL

2.12mL

1.06mL

21.17mL

4.23mL

2.12mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories